Drug Shortage Report for MYLAN-ABACAVIR/LAMIVUDINE
| Report ID | 65420 |
| Drug Identification Number | 02450682 |
| Brand name | MYLAN-ABACAVIR/LAMIVUDINE |
| Common or Proper name | ABACAVIR/LAMIVUDINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ABACAVIR LAMIVUDINE |
| Strength(s) | 600MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30BL |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2018-09-04 |
| Actual start date | 2018-09-04 |
| Estimated end date | 2019-02-15 |
| Actual end date | 2019-02-15 |
| Shortage status | Resolved |
| Updated date | 2019-02-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2019-02-16 | English | Compare |
| v8 | 2019-02-15 | French | Compare |
| v7 | 2019-02-15 | English | Compare |
| v6 | 2019-01-30 | French | Compare |
| v5 | 2019-01-30 | English | Compare |
| v4 | 2018-11-20 | French | Compare |
| v3 | 2018-11-20 | English | Compare |
| v2 | 2018-10-23 | French | Compare |
| v1 | 2018-10-23 | English | Compare |
Showing 1 to 9 of 9